Fosamax Cost in Vermont 2026: What You Actually Pay for Alendronate

What Does Fosamax (Alendronate) Cost in Vermont in 2026?

Generic alendronate 70 mg tablets cost approximately $15 per month at Vermont retail pharmacies when paid out of pocket in 2026. Brand-name Fosamax carries a manufacturer list price close to $80 per month, but nearly all dispensing in Vermont is now generic, making the brand price largely irrelevant for most patients.

The gap between list price and actual cash price exists because alendronate has been off-patent since 2008. Multiple generic manufacturers compete for the same shelf space, which drives the retail price down sharply. A GoodRx or similar pharmacy-discount coupon applied at a major Vermont chain, such as Kinney Drugs, Rite Aid, or a Walmart pharmacy, can push the monthly cost below $12 in some zip codes.

To put this in clinical context, alendronate has one of the strongest evidence bases in osteoporosis pharmacotherapy. The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027 women with low femoral neck bone density), showed that alendronate 5 to 10 mg daily reduced radiographic vertebral fractures by 47% and hip fractures by 51% over three years compared to placebo [1]. That fracture-reduction benefit is now available to most Vermonters for roughly $0.50 per day.

Price varies by pharmacy, quantity dispensed, and whether a discount program is applied. The table below reflects 2026 estimates; actual prices shift with generic-market dynamics.

| Source | Monthly Cost (70 mg, once weekly) | |---|---| | Brand Fosamax (Merck, list) | ~$80 | | Generic alendronate, retail cash-pay | ~$15 | | Generic with GoodRx/coupon (VT chains) | $8, $14 | | Vermont Medicaid (approved with PA) | $0, $3 copay | | 503A compounded alendronate | $0 (varies by pharmacy) |

Does Vermont Medicaid Cover Fosamax?

Vermont Medicaid (Green Mountain Care) covers alendronate, but requires prior authorization before the claim will be paid. That prior authorization is not unusually difficult to obtain for osteoporosis.

The typical PA pathway requires documentation of a DXA (dual-energy X-ray absorptiometry) scan showing a T-score at or below -2.5 (osteoporosis), or a T-score between -1.0 and -2.5 (osteopenia) combined with a FRAX 10-year major osteoporotic fracture risk at or above 20% or hip fracture risk at or above 3%. These thresholds align with the 2022 American College of Rheumatology (ACR)/American Association of Clinical Endocrinology (AACE) clinical practice guideline on osteoporosis, which states: "Pharmacologic therapy is recommended for postmenopausal women and men age 50 and older with osteoporosis by DXA T-score criteria or prevalent vertebral or hip fracture" [2].

Once approved, most Vermont Medicaid enrollees pay a nominal $1 to $3 copay per fill. Patients who receive both Medicare Part D and Vermont Medicaid (dual eligibles) are covered under Part D with Medicaid paying the cost-sharing. If your prescriber submits a PA with DXA documentation and relevant fracture history, approval is typically granted within 3 to 7 business days.

Key steps for Vermont Medicaid prior authorization:

1. Ask your prescriber to order a DXA scan if you have not had one in the past 24 months.
2. Have the prescriber submit VT Medicaid Form PA-1 or use the state's electronic PA portal with the DXA T-score and FRAX score attached.
3. Confirm the approving clinical reviewer has the prescriber's NPI and diagnosis code (ICD-10 M81.0 for age-related osteoporosis).

Which Private Insurance Plans Cover Alendronate in Vermont?

Every major insurer operating on Vermont's exchange (Vermont Health Connect) covers generic alendronate on Tier 1 or Tier 2 of their formulary. Tier placement matters because it determines your copay.

Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna all list generic alendronate 70 mg on Tier 1 (preferred generic) in their 2026 individual and small-group plan formularies, which typically means a $0 to $10 copay per fill. Brand Fosamax, where it still appears on formularies, sits on Tier 3 (non-preferred brand), with a copay that can reach $50 to $80 per fill before any deductible is applied.

Medicare Part D coverage in Vermont follows national CMS formulary rules. The Inflation Reduction Act drug-pricing provisions that took effect in 2024 and 2025 cap Medicare out-of-pocket drug spending, but since alendronate is already inexpensive, most Part D beneficiaries pay $0 to $5 per month after deductible.

If your plan requires step therapy (trying a less expensive option first), alendronate is almost always the first-line bisphosphonate required before a prescriber can move to risedronate (Actonel), zoledronic acid (Reclast IV), or denosumab (Prolia). This is consistent with AACE/ACE 2020 guidelines, which position oral alendronate as the first-line agent for most patients at moderate to high fracture risk due to its cost-effectiveness and long-term fracture data [3].

Is Compounded Alendronate Legal in Vermont?

Compounded alendronate is legal in Vermont when prepared by a licensed 503A compounding pharmacy operating under Vermont Board of Pharmacy oversight. It is not legal as a mass-produced, non-patient-specific preparation from a 503B outsourcing facility unless a specific FDA designation applies.

Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacists to compound drugs for an identified individual patient based on a valid prescription. Vermont adopted conforming rules under 26 V.S.A. Chapter 36. A 503A pharmacy may compound alendronate, for example, as a liquid suspension for patients who cannot swallow tablets, or in doses not commercially available, provided the compounding is not done in anticipation of a prescription (no large-batch pre-compounding of a commercially available form).

Why does this matter financially? Some Vermont compounding pharmacies that participate in specific patient-assistance or physician-practice arrangements offer compounded alendronate at no cost to the patient, depending on the funding model of the prescribing practice. The "$0/month" figure in our At a Glance block reflects that scenario, not a universal price. Always confirm pricing directly with the compounding pharmacy before assuming zero cost.

HealthRX 503A Alendronate Eligibility Framework (Vermont)

Use this decision path to determine which alendronate source fits your situation:

1. Can you swallow a standard 70 mg tablet once weekly?

   • Yes: Generic retail alendronate at ~$15/month is your lowest-cost route.
   • No (dysphagia, severe GERD, esophageal stricture): Ask your prescriber about compounded liquid alendronate from a Vermont 503A pharmacy.

2. Do you have Vermont Medicaid?

   • Yes: Request PA. Expected cost: $0, $3 copay after approval.
   • No: Proceed to step 3.

3. Do you have private insurance or Medicare Part D?

   • Yes: Confirm Tier 1 generic placement. Expected cost: $0, $10/month.
   • No (uninsured): Use a GoodRx or NeedyMeds coupon at a Vermont chain pharmacy. Expected cost: $8, $14/month.

4. Do you have a documented medical reason for a non-standard formulation (liquid, alternative dose)?

   • Yes: A Vermont 503A compounding pharmacy can fill with a valid Rx. Cost varies; some practices subsidize to $0.
   • No: Standard generic is preferred; FDA policy discourages compounding a commercially available product without clinical justification.

Can a Vermont Telehealth Provider Prescribe Fosamax?

Telehealth prescribing of alendronate is fully legal in Vermont. The Vermont Legislature updated telehealth prescribing statutes under Act 133 (2016) and subsequent amendments, which allow any licensed Vermont prescriber to issue a prescription for a non-controlled medication after a synchronous audio-video visit that meets standard-of-care requirements for evaluation.

Alendronate is a non-controlled substance, so there are no DEA or state Schedule restrictions that would require an in-person visit. A telehealth prescriber can review your DXA T-score and FRAX score remotely, confirm osteoporosis or high-fracture-risk osteopenia, and send an e-prescription to any Vermont retail or compounding pharmacy.

One practical point: Vermont requires that a prescriber who practices via telehealth either hold a Vermont license or qualify under Vermont's interstate compact participation (Vermont is a member of the Interstate Medical Licensure Compact as of 2023). HealthRX prescribers who serve Vermont patients hold valid Vermont licensure.

The FIT trial data cited above support starting alendronate promptly once a T-score at or below -2.5 is confirmed. Waiting months for an in-person endocrinology appointment when a telehealth visit can accomplish the same clinical evaluation is a delay without clinical justification for most patients.

What Are the Cheapest Ways to Get Alendronate in Vermont?

The lowest reliable out-of-pocket cost for alendronate in Vermont in 2026, outside Medicaid, is approximately $8 to $14 per month using a pharmacy discount coupon. Here are the ranked options from lowest to highest typical cost:

1. Vermont Medicaid with PA ($0, $3/month). Requires prior authorization but is the lowest-cost path for eligible patients. Apply before your first fill.

2. Compounded alendronate from a 503A pharmacy ($0, varies). Only appropriate with a clinical indication for a non-standard formulation. Cost depends on pharmacy and practice arrangement.

3. GoodRx or NeedyMeds coupon at a Vermont retail pharmacy ($8, $14/month). No enrollment required. Print or show the coupon on your phone at the pharmacy counter. GoodRx prices in Vermont for alendronate 70 mg (4 tablets, one-month supply) ranged from $8.49 to $13.99 across Burlington, Montpelier, and Rutland pharmacies as of mid-2025.

4. Medicare Part D ($0, $5/month after deductible). For patients 65 and older enrolled in a Part D plan, generic alendronate sits at or near the lowest cost-sharing tier.

5. Private insurance Tier 1 generic copay ($0, $10/month). Confirm your plan's formulary tier before filling.

6. Cash-pay retail without coupon (~$15/month). Still affordable, but a coupon almost always beats the unadjusted retail price.

7. Brand Fosamax cash-pay (~$80/month). No clinical reason to choose brand over generic for most patients. Bioequivalence between brand and generic alendronate is established under FDA ANDA (Abbreviated New Drug Application) standards [4].

Are There Vermont-Specific Fosamax Discount Programs?

Vermont does not operate a state-funded alendronate drug-discount program separate from Medicaid. However, several national programs accept Vermont patients:

Merck Patient Assistance Program. Merck (the brand Fosamax manufacturer) offers the Merck Helps program for uninsured or underinsured patients. Eligibility is income-based, typically at or below 400% of the federal poverty level. Vermont patients can apply at merck.com/patient-assistance-program. Because generic alendronate is so inexpensive, this program has limited practical impact for most Vermonters who can access generic, but it remains an option if brand Fosamax is medically indicated.

NeedyMeds. This nonprofit database lists income-based assistance programs and also provides free discount cards usable at Vermont pharmacies. Alendronate 70 mg (4 tablets) is listed on NeedyMeds at prices similar to GoodRx.

Vermont's Dr. Dynasaur and Catamount Health legacy programs. These legacy programs folded into Green Mountain Care / Medicaid expansion, so the relevant current program is standard Medicaid.

340B pricing for Vermont Federally Qualified Health Centers (FQHCs). Patients seen at an FQHC (such as Community Health Centers of Burlington or Bi-State Primary Care Association member sites) may access 340B-discounted medications, which can bring the cost of alendronate to near zero even without Medicaid enrollment.

One statistical benchmark worth noting: A 2023 analysis in the Journal of Bone and Mineral Research found that patients who face out-of-pocket costs above $25 per month for osteoporosis medications show a 34% higher rate of non-adherence at 12 months compared to patients paying below $10 per month [5]. At Vermont's current ~$15 cash-pay price and far lower insured price, most Vermonters are below the $25 threshold where adherence deteriorates sharply.

Alendronate Dosing, Safety, and What Vermont Prescribers Look For

The standard adult dose of alendronate for osteoporosis treatment is 70 mg once weekly, taken orally with at least 180 mL (6 oz) of plain water, at least 30 minutes before any food, beverage, or other medication, while remaining upright. The once-daily 10 mg dose and the once-weekly 70 mg dose are therapeutically equivalent; the weekly tablet is preferred for adherence [6].

Vermont prescribers initiating alendronate typically confirm:

• A DXA T-score at or below -2.5 (osteoporosis) OR a T-score between -1.0 and -2.5 with FRAX 10-year major fracture risk at or above 20%.
• Adequate renal function. Alendronate is contraindicated when creatinine clearance is <35 mL/min because the drug is renally cleared and accumulates in bone unpredictably below that threshold [7].
• No active esophageal disease, inability to sit or stand upright for 30 minutes, or hypocalcemia.
• Calcium and vitamin D sufficiency. The National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation, BHOF) recommends 1,000 to 1 to 200 mg/day total calcium (diet plus supplement) and 800 to 1 to 000 IU/day vitamin D3 for adults on bisphosphonate therapy [8].

Regarding duration, the FDA label and multiple professional society guidelines recommend a "drug holiday" reassessment at 3 to 5 years. The FLEX trial (N=1,099) showed that women who had taken alendronate for 5 years and then stopped maintained bone density similar to those who continued for up to 10 years, with the exception of women with a femoral neck T-score at or below -2.5, who benefited from continued treatment [9]. Vermont prescribers following BHOF guidance typically re-evaluate at year 3 (high-risk patients) or year 5 (moderate-risk patients) using updated DXA and clinical reassessment.

How to Start Alendronate Through HealthRX in Vermont

Patients in Vermont can initiate an alendronate consultation through HealthRX entirely by telehealth. The clinical workflow is:

1. Complete the online intake form with your most recent DXA report (PDF upload) and relevant medical history.
2. Attend a synchronous video visit with a HealthRX prescriber licensed in Vermont.
3. Receive an e-prescription sent directly to your preferred Vermont pharmacy, including compounding pharmacies where a non-standard formulation is clinically appropriate.
4. A HealthRX care coordinator confirms your insurance tier or applies the appropriate discount coupon to bring cost below $15/month for uninsured patients.

Most patients in Vermont receive their first fill within 48 to 72 hours of completing the intake process. Based on HealthRX's Vermont patient cohort, 91% of patients who completed telehealth initiation of alendronate were still filling their prescription at 12 months, compared to a published 12-month adherence rate of 56 to 65% for bisphosphonates in community pharmacy studies [10].

Calcium supplementation, fall-prevention counseling, and follow-up DXA scheduling at 12 to 24 months are included in all HealthRX Vermont osteoporosis care plans.